Elfatih Elzein

1.0k total citations
28 papers, 849 citations indexed

About

Elfatih Elzein is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Elfatih Elzein has authored 28 papers receiving a total of 849 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Physiology and 13 papers in Organic Chemistry. Recurrent topics in Elfatih Elzein's work include Adenosine and Purinergic Signaling (14 papers), Synthesis and Biological Evaluation (9 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Elfatih Elzein is often cited by papers focused on Adenosine and Purinergic Signaling (14 papers), Synthesis and Biological Evaluation (9 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Elfatih Elzein collaborates with scholars based in United States, Belarus and United Kingdom. Elfatih Elzein's co-authors include Jeff Zablocki, Venkata P. Palle, Rao Kalla, Dewan Zeng, William F. Kiesman, Thao Perry, Aleem Gangjee, Xiaofen Li, Luiz Belardinelli and Zhenhai Gao and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Elfatih Elzein

28 papers receiving 824 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elfatih Elzein United States 20 412 340 286 146 91 28 849
M. Ohno Japan 14 411 1.0× 296 0.9× 224 0.8× 85 0.6× 74 0.8× 34 734
Venkata P. Palle India 13 234 0.6× 202 0.6× 251 0.9× 99 0.7× 31 0.3× 26 586
Pedro Besada Spain 20 439 1.1× 404 1.2× 388 1.4× 61 0.4× 76 0.8× 50 964
Elizabeth A. Vecchio Australia 11 428 1.0× 305 0.9× 63 0.2× 52 0.4× 161 1.8× 13 589
Aliaa Abdelrahman Germany 21 442 1.1× 657 1.9× 246 0.9× 64 0.4× 108 1.2× 38 1.0k
Iain G. Dougall United Kingdom 17 528 1.3× 119 0.3× 98 0.3× 103 0.7× 229 2.5× 29 939
Ravi B. Marala United States 13 476 1.2× 57 0.2× 107 0.4× 258 1.8× 176 1.9× 17 790
Anthony H. Ingall United Kingdom 12 240 0.6× 356 1.0× 170 0.6× 173 1.2× 74 0.8× 14 789
Stephen J. Haleen United States 18 371 0.9× 117 0.3× 121 0.4× 294 2.0× 88 1.0× 31 822
E.A. van Schaick Netherlands 13 246 0.6× 192 0.6× 37 0.1× 38 0.3× 96 1.1× 17 575

Countries citing papers authored by Elfatih Elzein

Since Specialization
Citations

This map shows the geographic impact of Elfatih Elzein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elfatih Elzein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elfatih Elzein more than expected).

Fields of papers citing papers by Elfatih Elzein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elfatih Elzein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elfatih Elzein. The network helps show where Elfatih Elzein may publish in the future.

Co-authorship network of co-authors of Elfatih Elzein

This figure shows the co-authorship network connecting the top 25 collaborators of Elfatih Elzein. A scholar is included among the top collaborators of Elfatih Elzein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elfatih Elzein. Elfatih Elzein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fan, Peidong, Elfatih Elzein, & Lina Yao. (2024). Effect of TT-816, a novel immune response modifier targeting cannabinoid CB2 receptor, on antitumor immunity and cancer growth.. Journal of Clinical Oncology. 42(16_suppl). e14595–e14595. 1 indexed citations
2.
Koltun, Dmitry O., Rao Kalla, Thao Perry, et al.. (2017). Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII). Bioorganic & Medicinal Chemistry Letters. 28(3). 541–546. 5 indexed citations
3.
Rajamani, Sridharan, Nesrine El‐Bizri, Donglin Guo, et al.. (2016). The novel late Na+ current inhibitor, GS‐6615 (eleclazine) and its anti‐arrhythmic effects in rabbit isolated heart preparations. British Journal of Pharmacology. 173(21). 3088–3098. 28 indexed citations
4.
Koltun, Dmitry O., Elfatih Elzein, Tetsuya Kobayashi, et al.. (2016). Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic & Medicinal Chemistry Letters. 26(13). 3207–3211. 27 indexed citations
5.
Kiesman, William F., Elfatih Elzein, & Jeff Zablocki. (2009). A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers. Handbook of experimental pharmacology. 25–58. 77 indexed citations
6.
Kalla, Rao, Elfatih Elzein, Thao Perry, et al.. (2008). Selective, high affinity A2B adenosine receptor antagonists: N-1 monosubstituted 8-(pyrazol-4-yl)xanthines. Bioorganic & Medicinal Chemistry Letters. 18(4). 1397–1401. 33 indexed citations
7.
Elzein, Elfatih, Rao Kalla, Xiaofen Li, et al.. (2008). Discovery of a Novel A2BAdenosine Receptor Antagonist as a Clinical Candidate for Chronic Inflammatory Airway Diseases. Journal of Medicinal Chemistry. 51(7). 2267–2278. 51 indexed citations
8.
Elzein, Elfatih & Jeff Zablocki. (2008). A1adenosine receptor agonists and their potential therapeutic applications. Expert Opinion on Investigational Drugs. 17(12). 1901–1910. 73 indexed citations
9.
Elzein, Elfatih, Rao Kalla, Xiaofen Li, et al.. (2006). N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 17(1). 161–166. 24 indexed citations
10.
Elzein, Elfatih, Rao Kalla, Xiaofen Li, et al.. (2005). Novel 1,3-dipropyl-8-(1-heteroarylmethyl-1H-pyrazol-4-yl)-xanthine derivatives as high affinity and selective A2B adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(2). 302–306. 37 indexed citations
11.
Elzein, Elfatih, Kevin D. Shenk, Prabha N. Ibrahim, et al.. (2004). Novel inhibitors of fatty acid oxidation as potential metabolic modulators. Bioorganic & Medicinal Chemistry Letters. 14(4). 973–977. 6 indexed citations
12.
Elzein, Elfatih, Prabha N. Ibrahim, Venkata P. Palle, et al.. (2004). Structure–affinity relationships of 5′-aromatic ethers and 5′-aromatic sulfides as partial A1 adenosine agonists, potential supraventricular anti-arrhythmic agents. Bioorganic & Medicinal Chemistry Letters. 14(14). 3793–3797. 16 indexed citations
13.
Koltun, Dmitry O., Kevin D. Shenk, Elfatih Elzein, et al.. (2003). New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties. Bioorganic & Medicinal Chemistry Letters. 14(2). 549–552. 22 indexed citations
14.
Palle, Venkata P., Elfatih Elzein, Scott A. Gothe, et al.. (2002). Structure–affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorganic & Medicinal Chemistry Letters. 12(20). 2935–2939. 25 indexed citations
15.
Gao, Zhenhai, Zhihe Li, Stephen P. Baker, et al.. (2001). Novel Short-Acting A2A Adenosine Receptor Agonists for Coronary Vasodilation: Inverse Relationship between Affinity and Duration of Action of A2A Agonists. Journal of Pharmacology and Experimental Therapeutics. 298(1). 209–218. 108 indexed citations
16.
Gangjee, Aleem, et al.. (2001). Synthesis, Antifolate, and Antitumor Activities of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-pyrrolo[2,3-d]pyrimidines. Journal of Medicinal Chemistry. 44(12). 1993–2003. 57 indexed citations
17.
Zablocki, Jeff, Venkata P. Palle, Elfatih Elzein, et al.. (2001). ChemInform Abstract: 2‐Substituted Pi System Derivatives of Adenosine That Are Coronary Vasodilators Acting via the A2A Adenosine Receptor. ChemInform. 32(47). 1 indexed citations
18.
Zablocki, Jeff, Venkata P. Palle, Elfatih Elzein, et al.. (2001). 2-SUBSTITUTED PI SYSTEM DERIVATIVES OF ADENOSINE THAT ARE CORONARY VASODILATORS ACTING VIA THE A2AADENOSINE RECEPTOR. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 343–360. 29 indexed citations
19.
Gangjee, Aleem, et al.. (1996). Classical and Nonclassical Antifolates as Potential Antitumor, Antipneumocystis and Antitoxoplasma Agents. Current Pharmaceutical Design. 2(3). 263–280. 31 indexed citations
20.
Winek, Charles L., et al.. (1993). Interference of Herbal Drinks with Urinalysis for Drugs of Abuse. Journal of Analytical Toxicology. 17(4). 246–247. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Ohno Breakdown of academic impact, for papers by Venkata P. Palle Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Elizabeth A. Vecchio Breakdown of academic impact, for papers by Aliaa Abdelrahman Breakdown of academic impact, for papers by Iain G. Dougall Breakdown of academic impact, for papers by Ravi B. Marala Breakdown of academic impact, for papers by Anthony H. Ingall Breakdown of academic impact, for papers by Stephen J. Haleen Breakdown of academic impact, for papers by E.A. van Schaick
Rankless by CCL
2026